Global Airway/Lung Stents Market to Reach US$163.8 Million by 2030
The global market for Airway/Lung Stents estimated at US$119.3 Million in the year 2024, is expected to reach US$163.8 Million by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Tracheal, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$96.6 Million by the end of the analysis period. Growth in the Laryngeal segment is estimated at 5.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$32.8 Million While China is Forecast to Grow at 5.1% CAGR
The Airway/Lung Stents market in the U.S. is estimated at US$32.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$25.6 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.
Global Airway/Lung Stents Market - Key Trends & Drivers Summarized
What Are Airway/Lung Stents and Why Are They Essential for Respiratory Care?
Airway or lung stents are vital medical devices designed to maintain open passages in the respiratory tract, particularly in patients with conditions like chronic obstructive pulmonary disease (COPD), lung cancer, or tracheobronchial obstructions. These stents, made from materials like metal or silicone, are used to prevent airway collapse, helping patients breathe more easily and improving their overall quality of life. Airway stents are especially important for individuals who are not suitable candidates for surgery or where conventional treatments like medications are insufficient to manage severe respiratory obstructions. As the incidence of respiratory diseases continues to rise globally, the role of airway stents in patient care becomes even more critical.
How Are Technological Innovations Revolutionizing Airway Stent Design?
Technological advancements have significantly improved the design and functionality of airway/lung stents. Traditional silicone stents, valued for their removability and flexibility, are now complemented by metal stents, which offer superior durability and long-term structural support. More recently, hybrid stents have emerged, combining the benefits of both materials. Additionally, innovations such as drug-eluting stents, which slowly release medication to prevent infections or inflammation, have greatly reduced post-procedural complications. Imaging and navigation technologies have also improved the precision of stent placement, reducing the risk of stent migration or misplacement. These advancements are driving improved outcomes in patients undergoing stent placement.
What Is Driving the Increased Demand for Airway/Lung Stents?
The global demand for airway stents is steadily increasing due to several factors, including the rising prevalence of respiratory diseases such as COPD, lung cancer, and asthma. Air pollution, smoking, and aging populations have contributed to a surge in these conditions, necessitating the use of airway stents in critical care. Additionally, there is growing awareness among healthcare professionals and patients about the effectiveness of airway stents as a minimally invasive option to manage airway obstruction. This has led to the adoption of stenting procedures not only in emergency situations but also in long-term palliative care for patients with terminal illnesses.
What Factors Are Driving Growth in the Airway/Lung Stents Market?
The growth in the airway/lung stents market is driven by several factors, including advancements in stent materials and designs, the increasing prevalence of chronic respiratory diseases, and the growing demand for minimally invasive treatments. Technological innovations such as drug-eluting stents and improved imaging techniques are enhancing treatment outcomes and patient safety, contributing to market growth. The rising incidence of COPD and lung cancer, particularly in aging populations and regions with high air pollution, is increasing the need for airway stents. Additionally, improved access to healthcare in developing regions is expanding the adoption of these critical devices.
SCOPE OF STUDY:The report analyzes the Airway/Lung Stents market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:Material Type (Metal, Silicone, Hybrid); Product (Self-Expandable, Balloon-Expandable, Non-Expandable); Type (Tracheal, Laryngeal)
Geographic Regions/Countries:World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 41 Featured) - - BARD, A Becton, Dickinson Company
- Boston Scientific Corporation
- Changzhou Health Microport Medical Device Co., Ltd.
- Cook Group, Inc.
- EFER Endoscopy
- ENDO-FLEX GmbH
- Fuji Systems Corporation
- Hood Laboratories, Inc.
- Kapitex Healthcare Ltd.
- M.I.Tech Co., Ltd.
- Merit Medical Systems, Inc.
- Micro-Tech (Nanjing) Co., Ltd.
- Novatech SA
- S&G Biotech, Inc.
- Taewoong Medical
- Teleflex Inc.
AI INTEGRATIONSWe`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOROur new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.